The coronavirus vaccine being developed by Pfizer and BioNTech has been found to be 90% effective in preventing people from getting the virus, it has been confirmed.

Phase 3 of Pfizer’s trial involved 43,538 participants. They received two doses of either the immunisation or a placebo, with 90% protected from the virus within 28 days of having their jabs.